Thermo Fisher Q2 Revenues Increase 9 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported a 9-percent increase in second-quarter revenues, including a 28-percent jump in revenues generated by its Specialty Diagnostics segment.

For the period ended June 30, total revenues came in at $3.11 billion, up from $2.85 billion a year ago. Wall Street had a consensus estimate of $3.05 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.